Anika Therapeutics buy B. Riley
Start price
17.04.25
/
50%
€12.30
Target price
17.04.26
€18.48
Performance (%)
-35.37%
Price
12.01.26
€7.80
Summary
This prediction is currently active. The BUY prediction by B__Riley for Anika Therapeutics is performing very badly with a performance of -35.37%. This prediction currently runs until 17.04.26. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Anika Therapeutics | -3.659% | -3.659% |
| iShares Core DAX® | 2.331% | 5.140% |
| iShares Nasdaq 100 | 2.077% | 2.956% |
| iShares Nikkei 225® | 2.759% | 7.214% |
| iShares S&P 500 | 1.613% | 2.893% |
Comments by B__Riley for this prediction
In the thread Anika Therapeutics diskutieren
Anika Therapeutics, Inc. (NASDAQ: ANIK) is now covered by analysts at B. Riley. They set a "buy" rating and a $21.00 price target on the stock.
Ratings data for ANIK provided by MarketBeat

